Scientists think they have achieved the first gene editing inside the body, altering DNA in adults to try to treat a disease, though it's too soon to know if this will help. Preliminary results suggest that two men with a rare disorder now have a corrective gene at very low levels, which may not be enough to make the therapy a success. Still, it's a milestone toward one day doctoring DNA to treat many diseases caused by faulty genes, the AP reports. "This is a first step," said Dr. Joseph Muenzer of the University of North Carolina at Chapel Hill, who helped test the treatment. "It's just not potent enough." He gave the results Thursday at a conference in Orlando, Florida, and has consulted for the therapy's maker, California-based Sangamo Therapeutics. Researchers are working on a stronger version of the treatment.
Gene editing is intended as a more precise way to do gene therapy, to disable a bad gene or supply a good one that's missing. Trying it in adults to treat diseases is not controversial, and the DNA changes do not pass to future generations, unlike the recent case of a Chinese scientist who claims to have edited twin girls' genes when they were embryos. Sangamo's studies involve men with Hunter or Hurler syndrome, diseases caused by a missing gene that makes an enzyme to break down certain sugar compounds. Without it, sugars build up and damage organs, often killing people in their teens. In 2017, Brian Madeux of Arizona became the first person to try it. Results on Madeux and seven other Hunter patients, plus three with Hurler syndrome, suggest the treatment is safe, which was the main goal of these early experiments. An independent expert, Dr. Kiran Musunuru of the University of Pennsylvania, called the early results promising but said, "It's hard to be sure it's doing any good" until patients are studied longer. (The scientist who edited the twins' genes may be in big trouble.)